Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap-Reference-Cited by-同舟云学术

Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap

Published:2021-02 Issue:2 Volume:26 Page:283-288
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Starokozhko Viktoriia,Kallio Marko,Kumlin Howell Åsa^ORCID,Mäkinen Salmi Anna,Andrew-Nielsen Gunilla,Goldammer M.,Burggraf Manja,Löbker Wiebke^ORCID,Böhmer Anne,Agricola Eleonora,de Vries Corinne S.^ORCID,Pasmooij Anna M.G.,Mol Peter G.M.^ORCID

Funder

Horizon 2020

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference25 articles.

1. Are academic drug discovery efforts receiving more recognition with declining industry efficiency?;Bryans;Expert Opin. Drug Discov.,2019

2. Development of cell therapy medicinal products by academic institutes;de Wilde;Drug Discov. Today,2016

3. What are the respective roles of the public and private sectors in pharmaceutical innovation?;Sampat;Health Aff.,2011

4. Government as the First Investor in Biopharmaceutical Innovation: Evidence From New Drug Approvals 2010–2019;Cleary,2020

5. Translating healthcare innovation from academia to industry;Sanami;Adv. Mech. Eng.,2017

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International regulatory and publicly-funded initiatives to advance drug repurposing;Frontiers in Medicine;2024-05-31

2. The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report;Clinical Pharmacology & Therapeutics;2024-04-28

3. The European Innovation Network as a hub for medicines innovation in Europe;Nature Reviews Drug Discovery;2024-03-11

4. Nanotecnologias: regulação baseada em evidências;Vigilância Sanitária em Debate;2024-02-20

5. The needs, challenges, and opportunities from the academic researchers' perspective;Essentials of Translational Pediatric Drug Development;2024